![\"nuvolbioestadistica_v\"](\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2020\/04\/nuvolbioestadistica_v.jpg\" "\\"nuvolbioestadistica_v\\"")
\n\t\t\t\t\tServicios<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tSi necesitas nuestros servicios env\u00eda un correo electr\u00f3nico a ubidi@idibell.cat<\/a> con la informaci\u00f3n esencial de tu proyecto de investigaci\u00f3n y detalles sobre la ayuda solicitada.<\/p>\n A continuaci\u00f3n encontrareis la lista de nuestros principales servicios:<\/p>\n <\/p>\n\t\t\t\t\tAparatos<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t Bioestad\u00edstica La Unidad de Bioestad\u00edstica del IDIBELL ofrece servicios de consultor\u00eda estad\u00edstica a los investigadores del campus IDIBELL pero tambi\u00e9n a otros organismos p\u00fablicos y privados. La oferta de servicios incluye desde la planificaci\u00f3n de estudios hasta el an\u00e1lisis de los datos y la ayuda a la interpretaci\u00f3n de los resultados. El servicio trabaja de […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":679,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-733","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2025-03-02 12:43:25","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=733"}],"version-history":[{"count":6,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/733\/revisions"}],"predecessor-version":[{"id":25522,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/733\/revisions\/25522"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/679"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n
\nTeb\u00e9 C<\/strong>, Valls J, Satorra P, Tob\u00edas A.
\n BMC Med Res Methodol. 2020 Sep 21;20(1):235.\nImpact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol.
\nAbelenda-Alonso G, Rombauts A, Gudiol C, Meije Y, Clemente M, Ortega L, Ardanuy C, Niub\u00f3 J, Padull\u00e9s A, Videla S, Tebe C<\/strong>, Carratal\u00e0 J.
\nBMJ Open. 2020 Aug 20;10(8):e038957.\nDaptomycin plus Fosfomycin versus Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis. A Randomized Clinical Trial.
\nPujol M, Mir\u00f3 JM, Shaw E, Aguado JM, San-Juan R, Puig-Asensio M, Pigrau C, Calbo E, Montejo M, Rodriguez-\u00c1lvarez R, Garcia-Pais MJ, Pintado V, Escudero-S\u00e1nchez R, Lopez-Contreras J, Morata L, Montero M, Andr\u00e9s M, Pasquau J, Arenas MD, Padilla B, Murillas J, Jover-S\u00e1enz A, L\u00f3pez-Cortes LE, Garc\u00eda-Pardo G, Gasch O, Videla S, Hereu P, Teb\u00e9 C<\/strong>, Pallar\u00e8s N, Sanllorente M, Dom\u00ednguez M\u00c1, C\u00e0mara J, Ferrer A, Padull\u00e9s A, Cuervo G, Carratal\u00e0 J; BACSARM Trial Investigators.
\nClin Infect Dis. 2020 Jul 29:ciaa1081.\nHydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.
\nMitj\u00e0 O, Corbacho-Monn\u00e9 M, Ubals M, Tebe C<\/strong>, Pe\u00f1afiel J, Tobias A, Ballana E, Alemany A, Riera-Mart\u00ed N, P\u00e9rez CA, Su\u00f1er C, Laporte P, Admella P, Mitj\u00e0 J, Clua M, Bertran L, Sarquella M, Gavil\u00e1n S, Ara J, Argimon JM, Casabona J, Cuatrecasas G, Ca\u00f1adas P, Elizalde-Torrent A, Fabregat R, Farr\u00e9 M, Forcada A, Flores-Mateo G, Muntada E, Nadal N, Narejos S, Gil-Ortega AN, Prat N, Puig J, Qui\u00f1ones C, Reyes-Ure\u00f1a J, Ram\u00edrez-Viaplana F, Ruiz L, Riveira-Mu\u00f1oz E, Sierra A, Velasco C, Vivanco-Hidalgo RM, Sent\u00eds A, G-Beiras C, Clotet B, Vall-Mayans M; BCN PEP-CoV-2 RESEARCH GROUP.
\nClin Infect Dis. 2020 Jul 16:ciaa1009.\nUltrathin Bronchoscopy with and without Virtual Bronchoscopic Navigation: Influence of Segmentation on Diagnostic Yield.
\nDiez-Ferrer M, Morales A, Teb\u00e9 C<\/strong>, Cubero N, L\u00f3pez-Lisbona R, Padrones S, Aso S, Dorca J, Gil D, Rosell A; on behalf of the GUIBRO study group.
\nRespiration. 2019;97(3):252-258.\nA propensity-score-matched analysis of laparoscopic vs open surgery for rectal cancer in a population-based study.
\nManchon-Walsh P, Aliste L, Biondo S, Espin E, Pera M, Targarona E, Pallar\u00e8s N, Vernet R, Espin\u00e0s JA, Guarga A, Borr\u00e0s JM.
\nColorectal Dis. 2019 Apr;21(4):441-450.\nThe association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis.
\nTeb\u00e9 C<\/strong>, Mart\u00ednez-Laguna D, Carbonell-Abella C, et al.
\nOsteoporos Int. 2019;30(12):2407-2415. doi:10.1007\/s00198-019-05122-3\nFracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort.
\nMart\u00ednez-Laguna D, Teb\u00e9 C<\/strong>, Nogu\u00e9s X, et al.
\nPLoS One. 2018;13(9):e0203533. Published 2018 Sep 7. doi:10.1371\/journal.pone.0203533\nDifferential Mortality and the Excess Rates of Hip Fracture Associated With Type 2 Diabetes: Accounting for Competing Risks in Fracture Prediction Matters.
\nTeb\u00e9 C<\/strong>, Martinez-Laguna D, Moreno V, et al.
\nJ Bone Miner Res. 2018;33(8):1417-1421. doi:10.1002\/jbmr.3435\nPredictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections.
\nGomila A, Shaw E, Carratal\u00e0 J, et al.
\nAntimicrob Resist Infect Control. 2018;7:111. Published 2018 Sep 14. doi:10.1186\/s13756-018-0401-6\nEfficacy of \u03b2-Lactam\/\u03b2-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-\u03b2-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
\nGudiol C, Royo-Cebrecos C, Abdala E, Akova M, \u00c1lvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Mart\u00edn-D\u00e1vila P, Freifeld A, G\u00f3mez L, Gottlieb T, Gurgu\u00ed M, Herrera F, Manzur A, Maschmeyer G, Meije Y, Montejo M, Peghin M, Rodr\u00edguez-Ba\u00f1o J, Ruiz-Camps I, Sukiennik TC, Tebe C<\/strong>, Carratal\u00e0 J; BICAR Study Group.
\nAntimicrob Agents Chemother. 2017 Jul 25;61(8):e00164-17.\nGeriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?
\nAntonio M, Salda\u00f1a J, Carmona-Bayonas A, Navarro V, Teb\u00e9 C<\/strong>, Nadal M, Formiga F, Salazar R, Borr\u00e0s JM.
\nOncologist. 2017 Aug;22(8):934-943.\n\t\t\t\t![\"Judit-Pe\u00f1afiel-Mu\u00f1oz\"](\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2023\/07\/Judit-Penafiel-Munoz-150x150.jpg\" "\\"Judit-Pe\u00f1afiel-Mu\u00f1oz\\"")
\n\n\t\tJudith Pe\u00f1afiel Mu\u00f1oz\n\t<\/h4>\n
\n\t\tCONTACTA\n\t<\/h4>\n
\n\t\t\n\t\tBioestad\u00edstica\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tDOCUMENTOS\n\t<\/h4>\n
\n\t\t\n\t\tTarifas Generales (pdf)\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\tAviso legal i pol\u00edtica de privacidad REDCap\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\tIntroduction to REDCapDM package (video)\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\tIntroduction to REDCapDM package (pdf)\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquipo\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tCoordinadora\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tApoyo cient\u00edfico\t\t\t\t<\/a>\n\t\t\t\t\t\tCoordinadora\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
![\"r_logo.svg_\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/05\/r_logo.svg_.png\" "\\"r_logo.svg_\\""){kind=logo}
\n\t\t\t\t![\"shiny\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/05\/shiny.png\" "\\"shiny\\"")
\n\t\t\t\t![\"redcap\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/05\/redcap.png\" "\\"redcap\\"")
\n\t\t\t\t![\"\"](\"https:\/\/idibell.cat\/es\/wp-content\/plugins\/bb-plugin\/img\/pixel.png\"){kind=tracking}
\n\t\t\t\t\n\t\t\t\t\n\n","protected":false},"excerpt":{"rendered":"